Skip to content

Up2info.com

News / Analytics / Reviews

  • Stock Market Analysis
  • Corporate News
  • Financial News

Tag: ABBV

Amgen and GSK said to be adding products on TrumpRx

Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run...

wpadmin
March 14, 2026

AbbVie’s Skyrizi beaten by UCB’s Bimzelx in psoriatic arthritis

Belgian biopharma company UCB (UCBJY) announced on Wednesday that its arthritis therapy Bimzelx outperformed AbbVie’s...

wpadmin
March 11, 2026

AbbVie sees promising early-stage data for weight loss asset ABBV-295

Topline results from a phase 1 study of AbbVie's (ABBV) amylin analogue ABBV-295 for obesity showed the candidate led to...

wpadmin
March 9, 2026

FDA plans to relax testing rules to encourage biosimilar drugs: report

The U.S. Food and Drug Administration is reportedly easing some requirements for drugmakers developing copycat versions of...

wpadmin
March 9, 2026

FDA vaccine chief to leave the agency again

For the second time in less than a year, Vinay Prasad, the head of the U.S. Food and Drug Administration’s vaccines unit,...

wpadmin
March 7, 2026

AbbVie sees positive late-stage results for subcutaneous Skyrizi in Crohn’s

AbbVie (ABBV) said that a subcutaneous version of Skyrizi (risankizumab) for Crohn's disease met key goals in a phase 3...

wpadmin
March 2, 2026

Notable analyst calls this week: Alphabet, Comcast and IBM among top picks

The S&P 500 (SP500) closed in the red on Friday, after the week saw earnings reports from tech giants including Nvidia...

wpadmin
February 28, 2026

AbbVie a new outperform at RBC Capital Markets on durable growth

RBC Capital Markets has initiated coverage of AbbVie (ABBV) at outperform saying the company has underperformed based on...

wpadmin
February 25, 2026

AbbVie earmarks $380M to build two manufacturing facilities in Illinois

AbbVie (ABBV) will spend $380M to build two new active pharmaceutical ingredient plants at its current grounds in North...

wpadmin
February 23, 2026

AbbVie wins FDA approval for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia

AbbVie (ABBV) said Friday that the U.S. Food and Drug Administration has approved a supplemental new drug application for...

wpadmin
February 20, 2026

Posts navigation

Older posts

Powered By WordPress | Newsmagify